Delivery Order SPE2DB22D2206-SPE2DB24FFX39
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,303.44, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. This is a firm-fixed-price delivery order contract that runs through January 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $16,505.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, which are specialty pharmaceutical products. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. The contract is a delivery order, and there is no set-aside designation indicated....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract, valued at $6,602.82, is a firm-fixed-price delivery order without a set-aside designation. The award has an ultimate completion date of July 19, 2024. AmerisourceBergen, through its Corporate Office division, will provide these critical medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,256.11 firm fixed-price delivery order is for the supply of 4567645281 CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,861.39, is a delivery order for CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price arrangement. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award, valued at $14,122.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, which are pharmaceutical products. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of July 2, 2025. It is not designated as a set-aside contract, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,348.93, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a pharmaceutical product, with a ceiling value of $7,444.61. The contract is a firm fixed price delivery order and is not set aside. AmerisourceBergen Drug Corp is the prime contractor and there is no information provided about any subcontractors. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,640.41 and a performance period running through July 16, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $32,946.13, is for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFX39Delivery Order
This federal contract award, valued at $40,640.36, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract is a firm-fixed price delivery order with a completion date of March 5, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. This contract is not associated with a set-aside designation, indicating open competition. Additionally, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.6k | 3/4/24 |